Prevalence of CA 27.29 in primary breast cancer patients before the start of systemic treatment.
Rack B, Schindlbeck C, Jückstock J, Genss EM, Hepp P, Lorenz R, Tesch H, Schneeweiss A, Beckmann MW, Lichtenegger W, Sommer H, Friese K, Janni W; SUCCESS Study Group.
Rack B, et al. Among authors: sommer h.
Anticancer Res. 2010 May;30(5):1837-41.
Anticancer Res. 2010.
PMID: 20592389
Clinical Trial.